Skip to main content

Hillhouse Investment Management, Ltd.'s Form 4 filing

BeOne Medicines Ltd. (ONC) · filed Jun 12, 2023

Accession no.
0000902664-23-003537
Filed
Jun 12, 2023, 9:57 PM ET
Trade date
Jun 8-12, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hillhouse Investment Management, Ltd.CIK 000151058910% Owner
HHLR Advisors, Ltd.CIK 000176230410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 8, 2023Ordinary SharesSSaleDisposed−1,163,825$218.14F1−$253,881,789.95145,879,233IndirectPrice outlier
Jun 9, 2023Ordinary SharesSSaleDisposed−213,700HKD 130.35F2,F3Price in HKD, as filed−HKD 27,856,286.51145,665,533IndirectPrice outlier
Jun 9, 2023Ordinary SharesSSaleDisposed−328,952$217.02F1−$71,388,603.82145,336,581IndirectPrice outlier
Jun 12, 2023Ordinary SharesSSaleDisposed−281,400HKD 130.83F2,F4Price in HKD, as filed−HKD 36,816,181.08145,055,181IndirectPrice outlier
Jun 12, 2023Ordinary SharesSSaleDisposed−968,812$213.91F1−$207,240,996.95144,086,369IndirectPrice outlier

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares.

Referenced by the price of 3 transactions in Table I.

F2

The ordinary shares were sold through the Stock Exchange of Hong Kong, the price was paid in HKD.

Referenced by the price of 2 transactions in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD130.2787 to HKD130.550, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD131.7943 to HKD131.0298 inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)